IMMURON LTD-SPON ADR
IMRN · NASDAQ
更新于 2026-10-14 09:27:48
$1.04+0.00%
- 今日最高
- $1.10
- 今日最低
- $1.00
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K线图趋势，实际资料以交易页为准
关键数据
- 昨日开盘价
- $1.05
- 昨日收盘价
- $1.04
- 成交量
- 2.29万
- 市值
- $1452.82万
- 本益比（P/E）
- --
- 每股收益（EPS）
- $-0.01
昨日价格区间
$1.02$1.06
52周价格区间
$0.02$0.09
公司概况
- 板块
- 医疗保健
- 行业
- 生物技术
- 子行业
- 生物技术
- 总部
- 62 LYGON STREET, CARLTON, VIC, AUSTRALIA, 3053
- 国家
- AU
- 上市日期
- 1999-04-30
- 财年截止
- 六月
- 流通股数
- 3.22亿
- CIK
- 0001660046
Immuron Limited 是一家生物制药公司，在澳大利亚、美国及国际范围内研究和开发用于治疗和预防感染性疾病及免疫调节疾病的口服免疫疗法多克隆抗体。该公司总部位于澳大利亚卡尔顿。
财务指标
营业收入
2026-06-30
$357.9万
2025-12-31
$410.75万
2025-06-30
$329.26万
2025-03-31
$164.63万
营业支出
2026-06-30
$481.66万
2025-12-31
$486.99万
2025-06-30
$495.1万
2025-03-31
$245.69万
净利润
2026-06-30
-$194.67万
2025-12-31
-$188.38万
2025-06-30
-$276.43万
2025-03-31
-$136.35万
净利润率
2026-06-30
-54.39%
2025-12-31
-45.86%
2025-06-30
-83.95%
2025-03-31
-82.82%
每股收益
2026-06-30
--
2025-12-31
--
2025-06-30
$-0.01
2025-03-31
$0.00
息税折旧摊销前利润
2026-06-30
-$246.24万
2025-12-31
-$229.68万
2025-06-30
-$280.54万
2025-03-31
-$138.41万
有效税率
2026-06-30
9.27%
2025-12-31
18.21%
2025-06-30
--
2025-03-31
--
| 项目 | 2026-06-30 | 2025-12-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| 营业收入 | $357.9万 | $410.75万 | $329.26万 | $164.63万 |
| 营业支出 | $481.66万 | $486.99万 | $495.1万 | $245.69万 |
| 净利润 | -$194.67万 | -$188.38万 | -$276.43万 | -$136.35万 |
| 净利润率 | -54.39% | -45.86% | -83.95% | -82.82% |
| 每股收益 | -- | -- | $-0.01 | $0.00 |
| 息税折旧摊销前利润 | -$246.24万 | -$229.68万 | -$280.54万 | -$138.41万 |
| 有效税率 | 9.27% | 18.21% | -- | -- |
常见问题
风险提示
股价可能大幅波动，短时间内可能出现显著涨跌。 数字资产与衍生品交易可能涉及杠杆、流动性等额外风险。 本页内容仅供参考，不构成任何投资建议。 产品可用性与访问可能因地区及适用法规而异。